These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 640492)

  • 1. Influence of pentacyanoferrate complexes on platelet aggregation.
    Glusa E; Markwardt F
    Haemostasis; 1978; 7(1):54-6. PubMed ID: 640492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological effect of pentacyanonitrosylferrate and similar complex compounds].
    Markwardt F; Glusa E; Stürzebecher J; Jehn W; Kaiser B
    Acta Biol Med Ger; 1978; 37(3):469-78. PubMed ID: 735617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sodium nitroprusside and other pentacyanonitrosyl complexes on platelet aggregation.
    Glusa E; Markwardt F; Stürzebecher J
    Haemostasis; 1974; 3(5-6):249-56. PubMed ID: 4377561
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B; Grewe R; Loeschke K; Gerzer R
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sodium nitroprusside upon platelet function.
    Rivers R; Johns R
    Anesthesiology; 1989 Nov; 71(5):805-6. PubMed ID: 2817483
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: inhibition by sodium nitroprusside.
    Mehta J; Mehta P
    Circulation; 1979 Sep; 60(3):497-503. PubMed ID: 455612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyanide prevents the inhibition of platelet aggregation by nitroprusside, hydroxylamine and azide.
    Schwerin FT; Rosenstein R; Smith RP
    Thromb Haemost; 1983 Dec; 50(4):780-3. PubMed ID: 6665758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
    Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
    Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile alkylation of 4-nitrobenzotriazole and its platelet aggregation inhibitory activity.
    Singh D; Silakari O
    Bioorg Med Chem; 2017 Oct; 25(20):5260-5267. PubMed ID: 28789912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of platelet aggregation by dinitrosyl iron complexes with low molecular weight ligands].
    Mordvintsev PI; Rudneva VG; Vanin AF; Shimkevich LL; Khodorov BI
    Biokhimiia; 1986 Nov; 51(11):1851-7. PubMed ID: 3026500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Inhibition of platelet function by nitroprusside.
    Saxon A
    N Engl J Med; 1976 Jul; 295(5):281-2. PubMed ID: 934197
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma catecholamine response to hypotension induced by trimethaphan and by sodium nitroprusside during nitrous oxide-oxygen-fentanyl anesthesia.
    Hamaji M; Tashiro C; Oka N; Seki T; Kawashima Y; Yoshiya I
    Med J Osaka Univ; 1983 Sep; 34(1-2):37-41. PubMed ID: 6669139
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological effect of nitroprusside on platelet aggregation.
    Parrish PR; Larson DF
    J Extra Corpor Technol; 1999 Dec; 31(4):162-8. PubMed ID: 10915472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channels in smooth muscle.
    Karaki H; Weiss GB
    Gastroenterology; 1984 Oct; 87(4):960-70. PubMed ID: 6088352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the mechanism of action of vascular spasmolytics. 3. Effect of nitroprusside sodium, nitroglycerin, prenylamine and verapamil on the fluoride-induced contracture of the isolated coronary artery].
    Fermum R; Meisel P; Klinner U
    Acta Biol Med Ger; 1977; 36(2):245-55. PubMed ID: 410206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of sodium nitroprusside in the prevention and treatment of postoperative hypertension and the correction of the indicators of primary hemostasis in patients with vasorenal hypertension].
    Seleznev MN; Smirnova LA; Flerov EV; Krasin AIu; Stepanian TV
    Anesteziol Reanimatol; 1988; (3):31-4. PubMed ID: 3213988
    [No Abstract]   [Full Text] [Related]  

  • 19. Properties of purified soluble guanylate cyclase activated by nitric oxide and sodium nitroprusside.
    Lewicki JA; Brandwein HJ; Mittal CK; Arnold WP; Murad F
    J Cyclic Nucleotide Res; 1982; 8(1):17-25. PubMed ID: 6127356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
    Oda A; Druker BJ; Smith M; Salzman EW
    Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.